CVS Health (CVS) Tops Q1 EPS by 61c; raises guidance
Tweet
Share
E-mail
Get Alerts CVS Hot Sheet
Price: $94.99 +0.29%
Financial Fact:
Cost of revenues: 37.12B
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Cost of revenues: 37.12B
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
CVS Health (NYSE: CVS) reported Q1 EPS of $2.25, $0.61 better than the analyst estimate of $1.64. Revenue for the quarter came in at $94.6 billion versus the consensus estimate of $93.07 billion.
GUIDANCE:
CVS Health sees FY2025 EPS of $6.00-$6.20, versus the consensus of $5.91.
For earnings history and earnings-related data on CVS Health (CVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c
- KULR Technology Group (KULR) Misses Q2 EPS by 39c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
